New Taipei, Taiwan China Development Industrial Bank (CDIB) appeared to be the Corporate Investor, which was created in 1959. The leading representative office of defined Corporate Investor is situated in the Taipei. The fund was located in Asia if to be more exact in Taiwan.
The fund was created by Steven Chang. The overall number of key employees were 3.
The fund is constantly included in 2-6 investment rounds annually. Opposing the other organizations, this China Development Industrial Bank (CDIB) works on 13 percentage points more the average amount of lead investments. The top activity for fund was in 2001. When the investment is from China Development Industrial Bank (CDIB) the average startup value is more than 1 billion dollars. The common things for fund are deals in the range of more than 100 millions dollars. The real fund results show that this Corporate Investor is 4 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2007.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the China Development Industrial Bank (CDIB), startups are often financed by Venrock, U.S. Venture Partners (USVP), Mayfield Fund. The meaningful sponsors for the fund in investment in the same round are Venrock, U.S. Venture Partners (USVP), Mayfield Fund. In the next rounds fund is usually obtained by Venrock, U.S. Venture Partners (USVP), Mayfield Fund.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. If startup sums 3 of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Medical, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ant Financial, WebEx, Santarus.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AnBogen Therapeutics | $12M | 31 Jan 2024 | Taiwan, Taitung County, Taiwan | ||
Elixiron Immunotherapeutics | $27M | 23 Aug 2021 | New Taipei, Taiwan | ||
Yilu Tong | $3M | 11 Jul 2016 | Shanghai, China | ||
Ant Group | $4B | 22 Apr 2016 | Shangcheng District, Zhejiang, China | ||
iCHEF | $5M | 25 Feb 2016 | New Taipei, Taiwan | ||
Kaixin Dai | $34M | 30 Sep 2015 | Xuanwu District, Jiangsu, China | ||
WeDoctor | $394M | 24 Sep 2015 | Xiaoshan District, Zhejiang, China | ||
Zentera Systems | $4M | 04 Jun 2015 | San Jose, California, United States | ||
JHL Biotech | $35M | 19 Jun 2014 | Hsinchu, Taiwan Province, Taiwan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AnBogen Therapeutics | $12M | 31 Jan 2024 | Taiwan, Taitung County, Taiwan | ||
Elixiron Immunotherapeutics | $27M | 23 Aug 2021 | New Taipei, Taiwan | ||
Yilu Tong | $3M | 11 Jul 2016 | Shanghai, China | ||
Ant Group | $4B | 22 Apr 2016 | Shangcheng District, Zhejiang, China | ||
iCHEF | $5M | 25 Feb 2016 | New Taipei, Taiwan | ||
Kaixin Dai | $34M | 30 Sep 2015 | Xuanwu District, Jiangsu, China | ||
WeDoctor | $394M | 24 Sep 2015 | Xiaoshan District, Zhejiang, China | ||
Zentera Systems | $4M | 04 Jun 2015 | San Jose, California, United States | ||
JHL Biotech | $35M | 19 Jun 2014 | Hsinchu, Taiwan Province, Taiwan |
